Medeor Therapeutics Investors

20 investors on Angel Roster list Medeor Therapeutics in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Seed and the largest groups are based in the United States, China and Canada.

Investors are matched on the company name in their portfolio, so companies that share the name Medeor Therapeutics can appear together.

Investors listed
20
With verified email
50%
Most common stage
Seed
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 20 Medeor Therapeutics investors

The most complete profiles first. Showing 20 of 20.

  • Albert ChaVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareHospitalsWomen FoundedRobotics

    Portfolio: Ossium Health, Aligos Therapeutics, Olema Oncology, Synapse Biomedical and 81 more

    Verified email available

  • Jonathan LeffVerified

    Venture Capital, Investor · United States

    SeedSeries BHealth CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 66 more

    Verified email available

  • Mahendra ShahVerified

    Venture Capital, Private Equity Firm, Investor · United States

    Series BHealth CareHospitalsWomen FoundedRobotics

    Portfolio: Ossium Health, Aligos Therapeutics, Olema Oncology, Synapse Biomedical and 75 more

    Verified email available

  • Nathan DauVerified

    Venture Capital, Private Equity Firm, Investor · United States

    Series BHealth CareHospitalsWomen FoundedRobotics

    Portfolio: Ossium Health, Aligos Therapeutics, Olema Oncology, Synapse Biomedical and 75 more

    Verified email available

  • Peter KolchinskyVerified

    Venture Capital, Angel/Individual, Investor · United States

    SeedHealth CareEnterprise SoftwareInvestment ManagementBiotechnology

    Portfolio: Moderna Therapeutics, ARS Pharmaceuticals, Novavax, Zipline Medical and 6 more

    Verified email available

  • Sarah BhagatVerified

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Verified email available

  • Alan ColowickVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Verified email available

  • Jason PittsVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Verified email available

  • John ZhuVerified

    Venture Capital · China

    Health CareWomen FoundedBiotechnologyHealth Diagnostics

    Portfolio: GKHT Medical Technology, Helian Health, Forerunner Medical, Medeor Therapeutics and 27 more

    Contact details available

  • Mike PowellVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Verified email available

  • Qi ZhuVerified

    Venture Capital, Private Equity Firm · China

    Health CareHospitalsWomen FoundedInvestment Management

    Portfolio: Ossium Health, Aligos Therapeutics, Olema Oncology, Synapse Biomedical and 75 more

    Verified email available

  • Frank Kung

    Venture Capital, Founder, Private Equity Firm · United States

    Series BHealth CareHospitalsWomen FoundedInvestment Management

    Portfolio: Ossium Health, Aligos Therapeutics, Olema Oncology, Synapse Biomedical and 76 more

    Contact details available

  • Maha Katabi, PhD, CFA

    Hedge Fund, Venture Capital, Investor · Canada

    SeedHealth CareGeneticsWomen FoundedInvestment Management

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 64 more

    Contact details available

  • Perry Nisen

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Contact details available

  • Rebecca Zhu

    Venture Capital, Investor · China

    SeedHealth CareWomen FoundedManufacturingBiotechnology

    Portfolio: GKHT Medical Technology, Helian Health, Forerunner Medical, Medeor Therapeutics and 27 more

    Contact details available

  • Alfred Yue

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Contact details available

  • Andrew Goldberg

    Venture Capital, Private Equity Firm · United States

    Health CareHospitalsWomen FoundedRobotics

    Portfolio: Ossium Health, Aligos Therapeutics, Olema Oncology, Synapse Biomedical and 75 more

    Contact details available

  • Hooman Shahlavi

    Hedge Fund, Venture Capital · United States

    Health CareGeneticsWomen FoundedInvestment Management

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Contact details available

  • Nina Feng

    Venture Capital, Private Equity Firm · Taiwan

    Health CareHospitalsWomen FoundedRobotics

    Portfolio: Ossium Health, Aligos Therapeutics, Olema Oncology, Synapse Biomedical and 75 more

    Contact details available

  • Shan Fu

    Venture Capital, Private Equity Firm · China

    Health CareHospitalsWomen FoundedInvestment Management

    Portfolio: Ossium Health, Aligos Therapeutics, Olema Oncology, Synapse Biomedical and 75 more

    Contact details available

Frequently asked questions

How many Medeor Therapeutics investors are on Angel Roster?

Angel Roster lists 20 Medeor Therapeutics investors. 10 of them (50%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (20), Private Equity Firms (8) and Hedge Funds (2). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Medeor Therapeutics investors invest in?

Among those that list a stage, the most common are Seed (7) and Series B (4).

Where are Medeor Therapeutics investors based?

Most are based in the United States (14), China (4) and Canada (1).

Which companies have Medeor Therapeutics investors backed?

The most-backed portfolio companies among them are Apellis Pharmaceuticals (17), Visen Pharmaceuticals (17), Ascendis Pharma (17), Aclaris Therapeutics (17) and Coherus Biosciences (17).

How do I contact Medeor Therapeutics investors?

Create a free Angel Roster account to search and filter all 20, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.